Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [15387]

Researchers find a new targeted approach to shut down prostate cancer growth

Researchers find a new targeted approach to shut down prostate cancer growth

ESMO 2025: Blood test guides post-surgical immunotherapy for muscle-invasive bladder cancer

ESMO 2025: Blood test guides post-surgical immunotherapy for muscle-invasive bladder cancer

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

Precision reprogramming: How AI tricks cancer’s toughest cells

Precision reprogramming: How AI tricks cancer’s toughest cells

Targeted immunotherapy combination offers hope to older adults with leukaemia

Targeted immunotherapy combination offers hope to older adults with leukaemia

Combination therapy could expand treatment options for AML patients, extend survival

Combination therapy could expand treatment options for AML patients, extend survival

ESMO 2025: Research targets treatment resistance in neuroendocrine tumours

ESMO 2025: Research targets treatment resistance in neuroendocrine tumours

Disrupting cancer’s secret hubs: A new way to halt tumour growth

Disrupting cancer’s secret hubs: A new way to halt tumour growth

New insight in to role of immune system in colorectal cancer

New insight in to role of immune system in colorectal cancer

ESMO 2025: Novel treatment combination improves progression-free survival in metastatic, oestrogen-receptor-positive HER-2-negative breast cancer

ESMO 2025: Novel treatment combination improves progression-free survival in metastatic, oestrogen-receptor...

More from ecancer